The phenomenon of macro-TSH in a patient on oncoimmunotherapy: a clinical case report

Key Points

• Macro-TSH was identified in the patient during oncoimmunotherapy treatment, indicating potential hormonal irregularities.
• Clinical case highlights the need to monitor thyroid levels in patients undergoing oncoimmunotherapy, as thyroid function can be impacted.
• Analysis of this phenomenon sheds light on the complex interactions between immunotherapy and endocrine functions in patients with cancer treatment plans, emphasizing comprehensive care approaches for managing side effects in these patients: a critical aspect of cancer care decision-making processes firmly embedded within endocrinology practices and guidelines likely to be referenced in future case evaluations.